Ellipses Pharma and Kelun-Biotech Present EP0031 Data at ASCO 2026
LONDON, May 22, 2026 Ellipses Pharma and Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. announced that pivotal Phase 2 clinical trial...
Lunbotinib
Advertisement
Advertisement
